The Cardiovascular Cell Therapy Research Network (CCTRN) will be organized to conduct phase I and IIcollaborative trials of emerging cell based treatments of cardiovascular disease. A Steering Committee ofparticipating Investigators will select several (~4) protocols from among those proposed by the selectedClinical Centers. These studies will be organized, managed and administered by a Data Coordinating Center(DCC) which will select and oversee a core cell processing center, chemistry labs or imaging centers asnecessary for the selected studies. All trials will be monitored by a CCTRN Data and Safety MonitoringBoard as well as regulatory agencies such as the FDA which has oversight authority over INDs.The CCTRN DCC will be located within the Coordinating Center for Clinical Trials (CCCT) at The Universityof Texas School of Public Health in the Texas Medical Center in Houston. The persons named in thisproposal have considerable expertise in biostatististics, coordinating phase II and phase III clincial trials,epidemiology, cell processing, cell therapy, FDA procedures, genetics, data management and analysis, andadministration.In cooperation with the NHLBI and CCTRN investigators, the DCC will provide statistical, epidemiological,medical, and scientific leadership in 1) planning and developing the study design, organization andoperations 2) developing and implementing research protocols, detailed Manuals of Operations, appropriaterandomization schemes (if needed) and suitable analytical and statistical methodology for each investigation,3) appropriate data acquisition procedures and forms, 4) procedures for study event identification,abstraction, and review, and 5) operations for quality control and training. A comprehensive public web site isproposed for dissemination and communication with the professional and lay communities and studyparticipants. A secure web site will facilitate communications and coordination among participatinginvestigators, staff, and institutions, and will include a web-based data entry and management system thatprovides on-going monitoring of study progress. The success of each multicenter phase l/lltrial will dependheavily on the close working relationships and effective collaboration among the Data Coordinating Center,Clinical Centers, Project Office, and core labs. For over 30 years, the CCCT investigators and staff haveconsistently demonstrated the ability to promote and sustain effective collaboration in a series of important,highly successful, multicenter trials and cooperative studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HL087318-02S1
Application #
7689459
Study Section
Special Emphasis Panel (ZHL1-CSR-N (O1))
Program Officer
Skarlatos, Sonia
Project Start
2007-01-01
Project End
2011-12-31
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
2
Fiscal Year
2008
Total Cost
$1,457,156
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Other Domestic Higher Education
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77225
Traverse, Jay H; Henry, Timothy D (2017) Myocardial Injury as a New Target for Cell Therapy in Patients With Chronic Heart Failure: When Something Bad Is Actually Good? Circ Res 120:1857-1859
Jokerst, Jesse V; Cauwenberghs, Nicholas; Kuznetsova, Tatiana et al. (2017) Circulating Biomarkers to Identify Responders in Cardiac Cell therapy. Sci Rep 7:4419
Simari, Robert D (2017) Forging the Fate of Cellular Therapies for Cardiovascular Disease. Circ Res 120:1871-1873
Traverse, Jay H (2017) Is There a Role for Intravenous Stem Cell Delivery in Nonischemic Cardiomyopathy? Circ Res 120:256-258
Moyé, Lem (2016) Statistical Methods for Cardiovascular Researchers. Circ Res 118:439-53
Henry, Timothy D; Moyé, Lem; Traverse, Jay H (2016) Consistently Inconsistent-Bone Marrow Mononuclear Stem Cell Therapy Following Acute Myocardial Infarction: A Decade Later. Circ Res 119:404-6
Henry, Timothy D; Povsic, Thomas J (2015) Repeat Cell Therapy for Refractory Angina: Déjà vu All Over Again? Circ Cardiovasc Interv 8:
Schulman, Ivonne Hernandez; Suncion, Viky; Karantalis, Vasileios et al. (2015) Clinical research skills development program in cell-based regenerative medicine. Stem Cells Transl Med 4:118-22
Olson, Rachel E; Vojvodic, Rachel W; Bettencourt, Judy et al. (2014) Recruiting for Acute Myocardial Infarction Cell Therapy Trials: Challenges and Best Practices for the CCTRN. Clin Res (Alex) 28:71-77
Traverse, Jay H; Henry, Timothy D; Pepine, Carl J et al. (2014) One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction. JAMA 311:301-2

Showing the most recent 10 out of 29 publications